Eisaku Ogawa

Dr. Eisaku Ogawa

Shinshu University, Matsumoto, Japan

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2017 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
EOEisaku Ogawa
Eisaku Ogawa
YSYuki Sato
Yuki Sato
AMAkane Minagawa
Akane Minagawa
RORyuhei Okuyama
Ryuhei Okuyama

Verified
Journal Article
Open access
PDF file
YSYuki Sato
Yuki Sato
EOEisaku Ogawa
Eisaku Ogawa
RORyuhei Okuyama
Ryuhei Okuyama
Psoriasis is a chronic inflammatory skin condition caused by a combination of hereditary and environmental factors. Its development is closely related to the adaptive immune response. T helper 17 cells are major IL-17-producing cells, a function that plays an important role in the pathogenesis of psoriasis. However, recent findings have demonstrated that innate immune cells also contribute to the development of psoriasis. Innate lymphoid cells, γδ T cells, natural killer T cells, and natural killer cells are activated in psoriasis, contributing to disease pathology through IL-17-dependent and -independent mechanisms. The present review provides an overview of recent findings, demonstrating a role for innate immunity in psoriasis.

19 October 2017 in The Journal of Dermatology
Verified
Journal Article
Open access
PDF file
EOEisaku Ogawa
Eisaku Ogawa
RORyuhei Okuyama
Ryuhei Okuyama
TSTomoko Seki
Tomoko Seki
AKAya Kobayashi
Aya Kobayashi
Naoki OisoNaoki Oiso
Naoki Oiso
AKAkira Kawada
Akira Kawada
A local epidemiological survey of psoriasis was conducted from 19 February to 30 June 2016 in Matsumoto city, Nagano Prefecture, Japan. Patients were predominantly male (268 cases, 71.5% males vs 107 cases, 28.5% females). We estimated that the prevalence of psoriasis was 0.097% in the Matsumoto area. The clinical types of psoriasis identified were psoriasis vulgaris (90.7%), psoriatic arthritis (5.9%), pustular psoriasis (2.1%), guttate psoriasis (1.0%) and psoriatic erythroderma (0.3%). The topical therapeutic agents included corticosteroids (84.0%), vitamin D3 analogs (61.5%), and a combination of calcipotriol and betamethasone dipropionate (31.0%). Current systemic treatments included cyclosporin (9.0%), etretinate (7.4%) and methotrexate (1.3%). Biologic treatments included adalimumab (4.0%), ustekinumab (2.7%), infliximab (1.3%) and secukinumab (0.8%). Ultraviolet B therapy (11.3%) was the predominant phototherapy in which narrow band ultraviolet B therapy accounted for the majority, followed by psoralen and ultraviolet A therapy (1.0%). According to the recent evolution of psoriasis treatment, the use of biologics has been increasing. This study demonstrates the changes of treatment trends of psoriasis in a non‐metropolitan regional area.

10 December 2008 in Acta Dermato-Venereologica
Verified
Journal Article
Open access
PDF file
EOEisaku Ogawa
Eisaku Ogawa
RORyuhei Okuyama
Ryuhei Okuyama
HNHidetaka Niizuma
Hidetaka Niizuma
HTHachiro Tagami
Hachiro Tagami
STShigeru Tsuchiya
Shigeru Tsuchiya
SASetsuya Aiba
Setsuya Aiba

Verified
Journal Article
Open access
PDF file
EOEisaku Ogawa
Eisaku Ogawa
TETomohiro Edamitsu
Tomohiro Edamitsu
HOHidetaka Ohmori
Hidetaka Ohmori
KKKazuyoshi Kohu
Kazuyoshi Kohu
MKMineo Kurokawa
Mineo Kurokawa
RORyuhei Okuyama
Ryuhei Okuyama
The Runt-related transcription factor (Runx) family has been suggested to play roles in stem cell regulation, tissue development, and oncogenesis in various tissues/organs. In this study, we investigated the possible functions of Runx1 and Runx3 in keratinocyte differentiation. Both Runx1 and Runx3 proteins were detected in primary cultures of mouse keratinocytes. Proteins were localized in the nuclei of undifferentiated keratinocytes but translocated to the cytoplasm of differentiated cells. The siRNA-mediated inhibition of Runx1 and Runx3 expression increased expression of keratin 1 and keratin 10, which are early differentiation markers of keratinocytes. In contrast, overexpression of Runx1 and Runx3 suppressed keratin 1 and keratin 10 expression. Endogenous Runx1 and Runx3 proteins were associated with the promoter sequences of keratin 1 and keratin 10 genes in undifferentiated but not differentiated keratinocytes. In mouse skin, the inhibition of Runx1 and Runx3 expression by keratinocyte-specific gene targeting increased the ratios of keratin 1- and keratin 10-positive cells in the basal layer of the epidermis. On the other hand, inhibition of Runx1 and Runx3 expression did not alter the proliferation capacity of cultured or epidermal keratinocytes. These results suggest that Runx1 and Runx3 likely function to directly inhibit differentiation-induced expression of keratin 1 and keratin 10 genes but are not involved in the regulation of keratinocyte proliferation.

29 August 2021 in The Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
MMMaureen Tania Meling
Maureen Tania Meling
YKYukiko Kiniwa
Yukiko Kiniwa
EOEisaku Ogawa
Eisaku Ogawa
YSYuki Sato
Yuki Sato
RORyuhei Okuyama
Ryuhei Okuyama